NCT07523451

Brief Summary

The intra-articular injection is considered the first line of minimally invasive treatment of joint disease as it has an analgesic, antimicrobial effect and an immune system stimulating action as it is one of the most powerful detoxication agents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 5, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 13, 2026

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

April 5, 2026

Last Update Submit

April 5, 2026

Conditions

Keywords

Intra-articular injectionOzone gas,Internal derangement of temporomandibular jointOzonated water

Outcome Measures

Primary Outcomes (1)

  • Helkimo's Index

    Each patient was scored on a scale of 0-5 points. The total dysfunction index (Di) is calculated by summing the scores across all parameters, with the following classifications:

    6 months

Secondary Outcomes (1)

  • Maximum Mouth Opening

    6 months

Study Arms (2)

Study Group

EXPERIMENTAL

Patients will be treated with 2ml ozone oxygen mixture with concentration 5 micron/ml

Other: Patients will be treated with 2ml ozone oxygen mixture with concentration 10 micron/ml

Control Group

ACTIVE COMPARATOR

Patients will be treated with 2ml ozone oxygen mixture with concentration 10 micron/ml

Other: Patients will be treated with 2ml ozone oxygen mixture with concentration 5 micron/ml

Interventions

Patients will be treated with 2ml ozone oxygen mixture with concentration 5 micron/ml

Control Group

Patients will be treated with 2ml ozone oxygen mixture with concentration 10 micron/ml

Study Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients above 18 years old.
  • Patients suffering from sounds during condylar movements (clicking or popping).
  • Patients suffering from limited mouth opening and impaired joint movements.
  • Patients who did not respond to conservative treatment as a first line of treatment.

You may not qualify if:

  • Patients with history of condylar fracture.
  • Patients with degenerative joint disease.
  • Coagulopathy blood disorders.
  • Presence of infection at the site of injection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, Alexandria Governorate, 21523, Egypt

Location

Study Officials

  • yehia A El-Mahallawy, Phd

    Faculty of Dentistry, Alexandria University, Alexandria, Alexandria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2026

First Posted

April 13, 2026

Study Start

February 1, 2025

Primary Completion

October 30, 2025

Study Completion

April 1, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Locations